{"DataElement":{"publicId":"3918134","version":"1","preferredName":"Person Cancer Screening Plan Type","preferredDefinition":"Person; a human being._A term for diseases in which abnormal cells divide without control. Cancer cells can invade nearby tissues and can spread through the bloodstream and lymphatic system to other parts of the body._The use of any device, marker, or other means for the purpose of detecting the presence of disease, usually in asymptomatic individuals._The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._Planned; devised, contrived, or formed in design._Clinical testing designed to identify the presence of a specific cancer in an asymptomatic individual or population thought to be at risk of that specific cancer. The intent is to find cancers at the earliest possible stage in their development, in order to improve the chances for disease cure.","longName":"3918133v1.0:3918111v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3918133","version":"1","preferredName":"Person Cancer Screening Plan","preferredDefinition":"Person; a human being._A term for diseases in which abnormal cells divide without control. Cancer cells can invade nearby tissues and can spread through the bloodstream and lymphatic system to other parts of the body._The use of any device, marker, or other means for the purpose of detecting the presence of disease, usually in asymptomatic individuals._The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._Planned; devised, contrived, or formed in design.","longName":"2236731v1.0:3918131v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3918131","version":"1","preferredName":"Malignant Neoplasm Disease Screening Plan","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Checking for disease when there are no symptoms.:Planned; devised, contrived, or formed in design.","longName":"C9305:C15419:C25619","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Screening","conceptCode":"C15419","definition":"The use of any device, marker, or other means for the purpose of detecting the presence of disease, usually in asymptomatic individuals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E85B0BD9-ECE2-8F9F-E040-BB89AD43694E","latestVersionIndicator":"Yes","beginDate":"2013-10-09","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E85B0BD9-ECF3-8F9F-E040-BB89AD43694E","latestVersionIndicator":"Yes","beginDate":"2013-10-09","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"created for UAMS cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3918111","version":"1","preferredName":"Cancer Screening Type","preferredDefinition":"Clinical testing designed to identify the presence of a specific cancer in an asymptomatic individual or population thought to be at risk of that specific cancer. The intent is to find cancers at the earliest possible stage in their development, in order to improve the chances for disease cure.","longName":"3918111v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Bladder cancer","valueDescription":"Bladder Malignant Neoplasm","ValueMeaning":{"publicId":"3282841","version":"1","preferredName":"Bladder Malignant Neoplasm","longName":"3282841","preferredDefinition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A0A7-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C7D0-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Breast cancer","valueDescription":"Breast Malignant Neoplasm","ValueMeaning":{"publicId":"3282843","version":"1","preferredName":"Breast Malignant Neoplasm","longName":"3282843","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A0ED-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C7DA-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Colon or rectal cancer","valueDescription":"Colorectal Malignant Neoplasm","ValueMeaning":{"publicId":"3282840","version":"1","preferredName":"Colorectal Malignant Neoplasm","longName":"3282840","preferredDefinition":"(ko-lo-REK-tul) Having to do with the colon or the rectum.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal","conceptCode":"C13363","definition":"Relating to the colon and rectum, or to the entire large bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A084-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C7E6-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Kidney (renal cell) cancer","valueDescription":"Kidney Renal Cell Malignant Neoplasm","ValueMeaning":{"publicId":"3282839","version":"1","preferredName":"Kidney Renal Cell Malignant Neoplasm","longName":"3282839","preferredDefinition":"One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.: A glandular epithelial cell found in the kidney.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney","conceptCode":"C12415","definition":"One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secrete metabolic products and minerals from the blood, thus maintaining homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Renal Cortical Cell","conceptCode":"C33455","definition":"A cuboidal glandular epithelial cell found in the renal cortex.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A061-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C7F0-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Leukemia","valueDescription":"Leukemia","ValueMeaning":{"publicId":"2567354","version":"1","preferredName":"Leukemia","longName":"2567354","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D427-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-18","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C7FA-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Lung cancer","valueDescription":"Lung Malignant Neoplasm","ValueMeaning":{"publicId":"3282838","version":"1","preferredName":"Lung Malignant Neoplasm","longName":"3282838","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A030-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C804-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Lymphoma","valueDescription":"Lymphoma","ValueMeaning":{"publicId":"2567355","version":"1","preferredName":"Lymphoma","longName":"2567355","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D428-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-18","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C80E-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Melanoma skin cancer","valueDescription":"Skin Melanoma","ValueMeaning":{"publicId":"3282837","version":"1","preferredName":"Skin Melanoma","longName":"3282837","preferredDefinition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A00D-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C818-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Non-melanoma skin cancer (basal cell or squamous cell carcinoma)","valueDescription":"Nonmelanomatous Malignant Neoplasm","ValueMeaning":{"publicId":"3282835","version":"1","preferredName":"Nonmelanomatous Malignant Neoplasm","longName":"3282835","preferredDefinition":"Having to do with skin cancer that forms in the lower part of the epidermis (the outer layer of the skin) or in squamous cells, but not in melanocytes (skin cells that make pigment).: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonmelanomatous","conceptCode":"C14147","definition":"Having to do with skin cancer that forms in the lower part of the epidermis (the outer layer of the skin) or in squamous cells, but not in melanocytes (skin cells that make pigment).","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-9F8D-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C822-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Oral cavity or throat cancer","valueDescription":"Oral Cavity Or Throat Malignant Neoplasm","ValueMeaning":{"publicId":"3282836","version":"1","preferredName":"Oral Cavity Or Throat Malignant Neoplasm","longName":"3282836","preferredDefinition":"The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The narrow passage from the mouth to the cavity at the back of the mouth.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Cavity","conceptCode":"C12421","definition":"The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Throat","conceptCode":"C54272","definition":"The narrow passage from the mouth to the cavity at the back of the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-9FDD-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C82C-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Other, please specify:","valueDescription":"Other specify","ValueMeaning":{"publicId":"3232335","version":"1","preferredName":"Other specify","longName":"3232335","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1EB3697-8F1A-E94B-E040-BB89AD436A29","latestVersionIndicator":"Yes","beginDate":"2011-04-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C836-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Ovarian cancer","valueDescription":"Ovarian Carcinoma","ValueMeaning":{"publicId":"2593147","version":"1","preferredName":"Ovarian Carcinoma","longName":"2593147","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Carcinoma","conceptCode":"C4908","definition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286E976F-6E43-3730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C840-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Pancreatic cancer","valueDescription":"Pancreatic Carcinoma","ValueMeaning":{"publicId":"2672905","version":"1","preferredName":"Pancreatic Carcinoma","longName":"2672905","preferredDefinition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Carcinoma","conceptCode":"C3850","definition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A62B-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C84A-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Prostate cancer","valueDescription":"Prostate Gland Malignant Neoplasm","ValueMeaning":{"publicId":"3282842","version":"1","preferredName":"Prostate Gland Malignant Neoplasm","longName":"3282842","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A0CA-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C854-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Testicular cancer","valueDescription":"Testis Malignant Neoplasm","ValueMeaning":{"publicId":"3282833","version":"1","preferredName":"Testis Malignant Neoplasm","longName":"3282833","preferredDefinition":"Either of the paired male reproductive glands that produce the male germ cells and the male hormones.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testis","conceptCode":"C12412","definition":"Either of the paired male reproductive glands that produce the male germ cells and the male hormones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-9F66-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C85E-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Thyroid cancer","valueDescription":"Thyroid Gland Carcinoma","ValueMeaning":{"publicId":"2581280","version":"1","preferredName":"Thyroid Gland Carcinoma","longName":"2581280","preferredDefinition":"A carcinoma arising from the thyroid gland.  It is usually an adenocarcinoma and includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A8D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-18","modifiedBy":"ONEDATA","dateModified":"2006-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85AC74C-C868-0C4C-E040-BB89AD4377AD","beginDate":"2011-09-22","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3282831","version":"1","preferredName":"Cancer Diagnosis Type","preferredDefinition":"General term for detecting and classifying cancer in patients. (from CSP94):Type; a subdivision of a particular kind of thing.","longName":"C16213:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Diagnosis","conceptCode":"C16213","definition":"General term for detecting and classifying cancer in patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-9F27-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E85AC74C-C7BA-0C4C-E040-BB89AD4377AD","latestVersionIndicator":"Yes","beginDate":"2013-10-09","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"COOPERM","dateModified":"2015-02-24","changeDescription":"created for UAMS 10/9/13 cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Do you plan to be screened in","type":"Preferred Question Text","description":"Do you plan to be screened in the future for?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E85B0BD9-ED0B-8F9F-E040-BB89AD43694E","latestVersionIndicator":"Yes","beginDate":"2013-10-09","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-10-09","modifiedBy":"RODGERSC","dateModified":"2015-02-25","changeDescription":"created for UAMS 10/9/13 cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}